p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer

International Journal of Oncology

Volumn 10, Issue 4, 1997, Pages 801-806

  Shipman, Rob ^a   Schraml, Peter ^a,d   Moch, Holger ^b   Colombi, Marco ^a   Sauter, Guido ^b   Mihatsch, Michael J ^b   Ludwig, Christian U ^a,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c St Claraspital AG   (Switzerland)

^d ZLF   (Switzerland)

Author keywords

Bladder cancer; p53 expression; p53 gene alterations

Indexed keywords

PROTEIN P53;

ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; INVASIVE CARCINOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031002195     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.4.801     Document Type: Article

References (23)

1. Elder PA, Bell SM and Knowles MA: Deletion of two regions on chromosome 4 in bladder carcinoma: definition of a critical 750 kb region at 4p16.3. Oncogene 9: 3433-3436, 1994.
2. Takle LA and Knowles MA: Deletion mapping implicates two tumour suppressor genes on chromosome 8p in the development of bladder cancer. Oncogene 12: 1083-1087, 1996.
3. Gonzalez-Zulueta M, Shibata A, Ohneseit PA, Spruck CH, Busch C, Shamaa M, Elbaz M, Nichols PW, Gonzalgo ML, Malmstrom PU and Jones PA: High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J Natl Cancer Inst 87: 1383-1393, 1995.
4. Packenham JP, Taylor JA, Anna CH, White CM and Devereux TR: Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors. Mol Carcinogen 14: 147-151, 1995.
5. Tsai Y, Nichols PW, Hiti AL, Williams Z, Skinner DG and Jones PA: Allelic losses of chromosomes 9, 11 and 17 in human bladder cancer. Cancer Res 50: 44-47, 1990.
6. Shipman R, Schraml P, Colombi M, Raefle G and Ludwig CU: Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma. Hum Genet 91: 455-458, 1993.
7. Olumi AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bander LI and Jones PA: Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res 50: 7081-7083, 1990.
8. Fujita J, Srivastava SK, Kraus MH, Rhim JS, Tronick SR and Aaronson SA: Frequency of molecular alterations affecting ras proto-oncogenes in human urinary tract tumors. Proc Natl Acad Sci USA 82: 3849-3853, 198.
9. Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Home CHW and Neal DE: Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63: 967-970, 1991.
10. Ishikawa J, Xu H-J, Hu S-X, Yandell DW, Maeda S, Kamidono S, Benedict WF and Takahashi R: Inactivation of the retinoblastoma gene in human bladder and renal carcinomas. Cancer Res 51: 5736-5743, 1991.
11. Williamson MP, Elder PA and Knowles MA: The spectrum of TP53 mutations in bladder carcinoma. Gene Chromosome Cancer 9: 108-118, 1994.
12. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P and Vogelstein B: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706-709, 1991.
13. Oka K, Ishikawa J, Bruner JM, Takahashi R and Saya H: Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction. Mol Carcinogen 4: 10-13, 1991.
14. Presti JC, Reuter VE, Galan T, Fair WR and Cordon-Cardo C: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51: 5405-5409, 1991.
15. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Wilson JKV, Hamilton S and Vogelstein B: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717-7722, 1990.
16. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, and Collins FS: Mutations in the p53 gene occur in diverse tumour types. Nature 342: 705-708, 1989.
17. Harris CC and Hollstein M: Clinical implications of the p53 tumour suppressor gene. New Engl J Med 329: 1318-1327, 1993.
18. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
19. Caron de Fromentel C and Soussi T: TP53 tumour suppressor gene: a model for investigating human mutagenesis. Gene Chromosome Cancer 4: 1-15, 1992.
20. Cho Y, Gorina S, Jeffery PD and Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355, 1994.
21. Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
22. Chen PL, Chen Y, Bookstein R and Lee WH: Genetic mechanisms of tumour suppression by the human p53 gene. Science 250: 1576-1580, 1990.
23. Oyasu R, Nan L, Szumel C, Kawamata H and Hirohashi S: p53 gene mutations in human urothelial carcinomas: analysis by immunohistochemistry and single-strand conformation polymorphism. Modern Pathol 8: 170-176, 1995.